Research Focus

Former Employee. Pediatrics; Per Diem Physician Consultant

Recent additions – View all

1. Epidermal growth factor receptor (EGFR) genotyping of matched urine, plasma and tumor tissue from non-small cell lung cancer (NSCLC) patients (pts) treated with rociletinib

   Meeting Abstract

   Wakelee, H. A.; Gadgeel, S. M.; Goldman, J. W.; Reckamp, K. L.; Karlovich, C. A.; Melnikova, V.; Soria, J. C.; Yu, H. A.; Solomon, B. J.; Perol, M.; more...
   Journal of Clinical Oncology (2016)

   Fulltext@MSK | Save
2. Updated results from TIGER-X, a phase I/II open label study of rociletinib in patients (pts) with advanced, recurrent T790M-positive non-small cell lung cancer (NSCLC)

   Meeting Abstract

   Goldman, J. W.; Soria, J. C.; Wakelee, H. A.; Camidge, D. R.; Gadgeel, S. M.; Yu, H. A.; Reckamp, K. L.; Papadimitrakopoulou, V.; Perol, M.; Ou, S. H. I.; more...
   Journal of Clinical Oncology (2016)

   Fulltext@MSK | Save
3. Efficacy of rociletinib (CO-1686) in plasma-genotyped T790M-positive non-small cell lung cancer (NSCLC) patients (pts)

   Meeting Abstract

   Sequist, L. V.; Goldman, J. W.; Wakelee, H. A.; Camidge, D. R.; Yu, H. A.; Varga, A.; Solomon, B.; Oxnard, G. R.; Ou, S. H. I.; Papadimitrakopoulou, V.; more...
   Journal of Clinical Oncology (2015)

   Fulltext@MSK | Save